Breaking

medicine

Overactive Bladder Drugs May Not Raise Dementia Risk
Aid Ops

Overactive Bladder Drugs May Not Raise Dementia Risk

Overactive bladder drugs may not raise dementia risk, according to a new study published in JAMA Network Open.

Nabilah Razak · 07/11/2026
FDA Approves Tildrakizumab for Psoriatic Arthritis Treatment
Live Outbreaks

FDA Approves Tildrakizumab for Psoriatic Arthritis Treatment

The FDA has approved tildrakizumab for psoriatic arthritis treatment, expanding its use beyond plaque psoriasis.

Syuhada Zulkifli · 01/11/2026
LLMs reveal hidden layers in chronic pain assessment
Live Outbreaks

LLMs reveal hidden layers in chronic pain assessment

New research shows large language models may uncover hidden dimensions in chronic pain assessment that traditional severity scales miss, analyzing 131 patient…

Nabilah Razak · 26/10/2026
Physicians encouraged to adopt failure as learning tool
Aid Ops

Physicians encouraged to adopt failure as learning tool

Physicians encouraged to adopt failure as a learning tool to improve healthcare excellence.

Syuhada Zulkifli · 24/10/2026
Obesity Drug Trial Results Disappoint Amid Lilly, Novo Competition
Field Reports

Obesity Drug Trial Results Disappoint Amid Lilly, Novo Competition

Boehringer Ingelheim's obesity drug trial results show a 13.1% weight loss, a disappointing outcome in the competitive market dominated by Eli Lilly…

Syuhada Zulkifli · 03/10/2026